Annual report pursuant to Section 13 and 15(d)

EQUITY TRANSACTIONS (Details Narrative)

v3.22.2
EQUITY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Feb. 10, 2022
Apr. 02, 2021
Apr. 03, 2020
Mar. 31, 2022
Mar. 24, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Feb. 28, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2022
Mar. 31, 2021
Subsidiary, Sale of Stock [Line Items]                              
Proceeds from issuance of common stock and warrants                           $ 17,456,092 $ 7,260,869
Share price     $ 1.41                        
Warrants Cancelled                           199,110  
Offering price         $ 15,000,000                    
Restricted stock grant     24,822                        
Payments to satify tax withholding                           $ 88,118 $ 132,527
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number                 0           0
Stock based compensation expense                           $ 750,621 $ 779,421
Interest rate                           25.00%  
Vesting period 36 months                            
Intrinsic value per share                           $ 1.46  
Unrecognized compensation cost to share based                           $ 2,724,000  
Weighted average period                           3 years 3 months 18 days  
N 2010 Stock Plan [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Restricted stock grant     23,893                        
Equity 2020 Plan [Member] | Chief Executive Officer [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Options granted 192,600                            
Equity 2020 Plan [Member] | Chief Medicall Officer [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Options granted 100,200                            
Equity 2020 Plan [Member] | Chief Operating Officer [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Options granted 100,200                            
Equity 2020 Plan [Member] | Chief Financial Officer [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Options granted 100,200                            
Equity Option [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Proceeds from options exercised                           $ 28,325  
Stock issued for exercise of options                           11,562  
Restricted Stock Units (RSUs) [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Conversion of Stock, Shares Converted       18,221   18,221 18,221 18,221 32,189   32,189   29,866    
Conversion of Stock, Shares Issued                       29,866      
Stock based compensation expense                           $ 150,000 $ 175,000
Restricted Stock Units (RSUs) [Member] | Non Employee Directors [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Stock cancelled in exchange for withholding tax, shares       7,289   7,289 7,289 7,289 12,875   12,876 11,947 11,947    
Payments to satify tax withholding       $ 10,641   $ 13,557 $ 28,134 $ 35,786 $ 26,136   $ 31,802 $ 16,128 $ 24,251    
Restricted Stock Units (RSUs) [Member] | Plan 2020 [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Restricted stock grant   24,295                          
Warrants [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Warrants exercised, common shares issued                           531,167  
Proceeds from warrant exercises                           $ 820,938  
Warrants Cashless Basis [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Warrants exercised cashless basis                           874,664  
Stock issued from exercise of warrants cashless basis                           675,554  
Maxim Group L L C [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Share price                 $ 9.00           $ 9.00
CEO [Member] | Equity 2020 Plan [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Options granted                           266,888  
Share price                           $ 5.17  
Maxim Group L L C [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Proceeds from issuance of common stock and warrants                           $ 11,659,044  
Stock issued new, shares issued                           1,380,555  
Investor Relations Consultant [Member] | Restricted Stock Units (RSUs) [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Stock Issued During Period, Shares, Restricted Stock Award, Gross                   7,758          
Stock Issued During Period, Value, Restricted Stock Award, Gross                   $ 18,000          
Stock based compensation expense                           $ 16,500 $ 1,500
Offering Agreement [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Proceeds from issuance of common stock and warrants                           $ 4,947,785  
Stock issued new, shares issued                           626,000  
Stock sale - average price per share                           $ 7.90  
Offering Agreement [Member] | Hc Wainwright [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Payment of commissions                           $ 126,922 224,825
Offering Agreement [Member] | Other Offering Expense [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Payment of stock issuance costs                           $ 2,154 8,472
Common Stock Sales Agr [Member] | Wainwright [Member]                              
Subsidiary, Sale of Stock [Line Items]                              
Proceeds from issuance of common stock and warrants                             $ 7,260,869
Stock issued new, shares issued                             2,685,600
Stock sale price per share                 $ 2.70           $ 2.70